Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079118069> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2079118069 endingPage "1938" @default.
- W2079118069 startingPage "1933" @default.
- W2079118069 abstract "The pharmacology, pharmacokinetics, clinical efficacy, safety, adverse effects, dosage and administration, and role in therapy of afatinib in the management of non-small-cell lung cancer (NSCLC) are reviewed.Afatinib (Gilotrif, Boehringer Ingelheim) is a novel oral tyrosine kinase inhibitor (TKI) recently approved for the first-line treatment of patients with NSCLC whose tumors are driven by activating mutations of genes coding for epidermal growth factor receptor (EGFR). Afatinib is also an inhibitor of a specific EGFR mutation (T790M) that causes resistance to first-generation EGFR-targeted TKIs in about half of patients receiving those drugs. The recommended dosage is 40 mg once daily. In a Phase III trial completed last year, patients with EGFR-mutated NSCLC who were treated with afatinib had a twofold higher response rate than those receiving standard combination chemotherapy (56% versus 23%) and significantly longer progression-free survival (11.0 months versus 5.6 months). Other studies indicated that afatinib may offer advantages over standard chemotherapy for NSCLC in terms of enhanced symptom control and quality of life and is modestly effective in cases involving EGFRT790M-related acquired resistance to the TKIs erlotinib and gefitinib. Among clinical trial participants, afatinib was generally well tolerated, with the most common grade I or II adverse events being diarrhea and rash or acne; grade III or IV events were infrequent.Afatinib is a novel TKI that is efficacious and well tolerated in patients with NSCLC associated with activating EGFR mutations, including cases involving the T790M resistance mutation. It has possible applications in other EGFR mutation- positive cancers." @default.
- W2079118069 created "2016-06-24" @default.
- W2079118069 creator A5016348831 @default.
- W2079118069 creator A5083099771 @default.
- W2079118069 date "2014-11-15" @default.
- W2079118069 modified "2023-09-26" @default.
- W2079118069 title "Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer" @default.
- W2079118069 cites W1974024530 @default.
- W2079118069 cites W1989931815 @default.
- W2079118069 cites W2063391304 @default.
- W2079118069 cites W2079251910 @default.
- W2079118069 cites W2088093215 @default.
- W2079118069 cites W2088842290 @default.
- W2079118069 cites W2096198395 @default.
- W2079118069 cites W2104874286 @default.
- W2079118069 cites W2114095518 @default.
- W2079118069 cites W2114953089 @default.
- W2079118069 cites W2125760261 @default.
- W2079118069 cites W2126696135 @default.
- W2079118069 cites W2132540363 @default.
- W2079118069 cites W2138851777 @default.
- W2079118069 cites W2152905269 @default.
- W2079118069 cites W2160336497 @default.
- W2079118069 cites W2169961966 @default.
- W2079118069 doi "https://doi.org/10.2146/ajhp130654" @default.
- W2079118069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25349236" @default.
- W2079118069 hasPublicationYear "2014" @default.
- W2079118069 type Work @default.
- W2079118069 sameAs 2079118069 @default.
- W2079118069 citedByCount "15" @default.
- W2079118069 countsByYear W20791180692015 @default.
- W2079118069 countsByYear W20791180692016 @default.
- W2079118069 countsByYear W20791180692017 @default.
- W2079118069 countsByYear W20791180692018 @default.
- W2079118069 countsByYear W20791180692019 @default.
- W2079118069 countsByYear W20791180692020 @default.
- W2079118069 countsByYear W20791180692022 @default.
- W2079118069 crossrefType "journal-article" @default.
- W2079118069 hasAuthorship W2079118069A5016348831 @default.
- W2079118069 hasAuthorship W2079118069A5083099771 @default.
- W2079118069 hasConcept C121608353 @default.
- W2079118069 hasConcept C126322002 @default.
- W2079118069 hasConcept C143998085 @default.
- W2079118069 hasConcept C197934379 @default.
- W2079118069 hasConcept C2776256026 @default.
- W2079118069 hasConcept C2776694085 @default.
- W2079118069 hasConcept C2777930144 @default.
- W2079118069 hasConcept C2778087573 @default.
- W2079118069 hasConcept C2778570526 @default.
- W2079118069 hasConcept C2779438470 @default.
- W2079118069 hasConcept C2780580887 @default.
- W2079118069 hasConcept C2780586478 @default.
- W2079118069 hasConcept C71924100 @default.
- W2079118069 hasConceptScore W2079118069C121608353 @default.
- W2079118069 hasConceptScore W2079118069C126322002 @default.
- W2079118069 hasConceptScore W2079118069C143998085 @default.
- W2079118069 hasConceptScore W2079118069C197934379 @default.
- W2079118069 hasConceptScore W2079118069C2776256026 @default.
- W2079118069 hasConceptScore W2079118069C2776694085 @default.
- W2079118069 hasConceptScore W2079118069C2777930144 @default.
- W2079118069 hasConceptScore W2079118069C2778087573 @default.
- W2079118069 hasConceptScore W2079118069C2778570526 @default.
- W2079118069 hasConceptScore W2079118069C2779438470 @default.
- W2079118069 hasConceptScore W2079118069C2780580887 @default.
- W2079118069 hasConceptScore W2079118069C2780586478 @default.
- W2079118069 hasConceptScore W2079118069C71924100 @default.
- W2079118069 hasIssue "22" @default.
- W2079118069 hasLocation W20791180691 @default.
- W2079118069 hasLocation W20791180692 @default.
- W2079118069 hasOpenAccess W2079118069 @default.
- W2079118069 hasPrimaryLocation W20791180691 @default.
- W2079118069 hasRelatedWork W2057313101 @default.
- W2079118069 hasRelatedWork W2101959192 @default.
- W2079118069 hasRelatedWork W2174769990 @default.
- W2079118069 hasRelatedWork W2762724643 @default.
- W2079118069 hasRelatedWork W2906574801 @default.
- W2079118069 hasRelatedWork W2968201252 @default.
- W2079118069 hasRelatedWork W2979585789 @default.
- W2079118069 hasRelatedWork W3000070469 @default.
- W2079118069 hasRelatedWork W4281670385 @default.
- W2079118069 hasRelatedWork W4281690819 @default.
- W2079118069 hasVolume "71" @default.
- W2079118069 isParatext "false" @default.
- W2079118069 isRetracted "false" @default.
- W2079118069 magId "2079118069" @default.
- W2079118069 workType "article" @default.